Discover
OFIX
Orthofix Medical Inc.
9.17
2 x 6.51
2 x 11.59
bid
ask
+
0.17
1.89%
2 @ 04:01 PM
9.17 +0.00 (0.00%)
| Ytd | -39.51% | |
| 1y | -34.59% |
8.99
day range
9.23
8.64
52 week range
16.23
| Open | 9.00 | Prev Close | 9.00 | Low | 8.99 | High | 9.23 | Mkt Cap | 373.52M |
| Vol | 314.18K | Avg Vol | 369.51K | EPS | -1.55 | P/E | N/A | Forward P/E | -1733.00 |
| Beta | 1.05 | Short Ratio | 3.89 | Inst. Own | 92.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 9.74 | 200-d Avg | 11.55 | 1yr Est | 24.40 |
| Income Statement | |||
| Total Revenue | 210.93M | ||
| Revenues (USD) | 210.93M | ||
| Cost of Revenue | 61.23M | ||
| Gross Profit | 149.71M | ||
| Operating Expenses | 157.84M | ||
| Research and Development Expense | 15.94M | ||
| Selling, General and Administrative Expense | 138.03M | ||
| Operating Income | -8.13M | ||
| Interest Expense | 6.09M | ||
| Income Tax Expense | 801.00K | ||
| Net Income | -15.80M | ||
| Net Income Common Stock | -15.80M | ||
| Net Income Common Stock (USD) | -15.80M | ||
| Consolidated Income | -15.80M | ||
| Earnings per Basic Share | -0.39 | ||
| Earnings per Basic Share (USD) | -0.39 | ||
| Earnings per Diluted Share | -0.39 | ||
| Earning Before Interest & Taxes (EBIT) | -8.91M | ||
| Earning Before Interest & Taxes (USD) | -8.91M | ||
| Weighted Average Shares | 40.91M | ||
| Weighted Average Shares Diluted | 40.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 104.41M | ||
| Cash and Equivalents (USD) | 104.41M | ||
| Trade and Non-Trade Receivables | 135.82M | ||
| Current Assets | 446.13M | ||
| Property, Plant & Equipment Net | 130.76M | ||
| Total Assets | 873.02M | ||
| Debt Current | 125.00K | ||
| Total Debt | 234.62M | ||
| Current Liabilities | 157.01M | ||
| Debt Non-Current | 234.49M | ||
| Total Liabilities | 443.84M | ||
| Accumulated Retained Earnings (Deficit) | -405.04M | ||
| Accumulated Other Comprehensive Income | -277.00K | ||
| Shareholders Equity | 429.18M | ||
| Shareholders Equity (USD) | 429.18M | ||
| Assets Non-Current | 426.89M | ||
| Total Debt (USD) | 234.62M | ||
| Goodwill and Intangible Assets | 260.91M | ||
| Inventory | 184.48M | ||
| Liabilities Non-Current | 286.83M | ||
| Trade and Non-Trade Payables | 63.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.27M | ||
| Net Cash Flow from Financing | 2.45M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.46M | ||
| Capital Expenditure | -12.65M | ||
| Issuance (Purchase) of Equity Shares | 2.63M | ||
| Issuance (Repayment) of Debt Securities | -25.00K | ||
| Net Cash Flow from Investing | -12.65M | ||
| Net Cash Flow from Operations | -6.22M | ||
| Effect of Exchange Rate Changes on Cash | -45.00K | ||
| Share Based Compensation | 7.74M | ||